EditorialEditorial
The COVID-19 Vaccine Landscape: What a Rheumatologist Needs to Know
Katie Bechman, Mrinalini Dey, Mark Yates, Marwan Bukhari, Kevin Winthrop and James B. Galloway
The Journal of Rheumatology August 2021, 48 (8) 1201-1204; DOI: https://doi.org/10.3899/jrheum.210106
Katie Bechman
1K. Bechman, PhD, M. Yates, PhD, J.B. Galloway, PhD, Centre for Rheumatic Diseases, Kings College London, London, UK;
Mrinalini Dey
2M. Dey, MB BChir., Institute of Life Course and Medical Sciences, University of Liverpool, and Rheumatology, Aintree University Hospital, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK;
Mark Yates
1K. Bechman, PhD, M. Yates, PhD, J.B. Galloway, PhD, Centre for Rheumatic Diseases, Kings College London, London, UK;
Marwan Bukhari
3M. Bukhari, PhD, Rheumatology, Royal Lancaster Infirmary, Lancaster, UK;
Kevin Winthrop
4K. Winthrop, MD, MPH, Division of Infectious Diseases, Oregon Health & Science University, Portland, Oregon, USA.
James B. Galloway
1K. Bechman, PhD, M. Yates, PhD, J.B. Galloway, PhD, Centre for Rheumatic Diseases, Kings College London, London, UK;
Data supplements
210106 Author Interview
In this issue
The Journal of Rheumatology
Vol. 48, Issue 8
1 Aug 2021
The COVID-19 Vaccine Landscape: What a Rheumatologist Needs to Know
Katie Bechman, Mrinalini Dey, Mark Yates, Marwan Bukhari, Kevin Winthrop, James B. Galloway
The Journal of Rheumatology Aug 2021, 48 (8) 1201-1204; DOI: 10.3899/jrheum.210106